Increased Expression of Stem Cell Factor and Its Receptor After Left Ventricular Assist Device Support: A Potential Novel Target for Therapeutic Interventions in Heart Failure

Journal of Heart and Lung Transplantation

Volumn 27, Issue 7, 2008, Pages 701-709

  Jahanyar, Jama ^a   Youker, Keith A ^b   Torre Amione, Guillermo ^b   Koerner, Michael M ^a   Bruckner, Brian ^b   Noon, George P ^a,b   Loebe, Matthias ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHYMASE; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; TRYPTASE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR EQUIPMENT; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; GENE SEQUENCE; HEART FAILURE; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMPLANTATION; IN SITU HYBRIDIZATION; LEYDIG CELL; MALE; MAST CELL; MUSCLE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MAST CELLS; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-KIT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELL FACTOR;

EID: 45549101495     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.03.021     Document Type: Article

References (35)

1. Brower G.L., and Janicki J.S. Pharmacologic inhibition of mast cell degranulation prevents left ventricular remodeling induced by chronic volume overload in rats. J Card Fail 11 (2005) 548-556
2. Hara M., Ono K., Hwang M.W., et al. Evidence for a role of mast cells in the evolution to congestive heart failure. J Exp Med 195 (2002) 375-381
3. Janicki J.S., Brower G.L., Gardner J.D., et al. Cardiac mast cell regulation of matrix metalloproteinase-related ventricular remodeling in chronic pressure or volume overload. Cardiovasc Res 69 (2006) 657-665
4. Matsumoto T., Wada A., Tsutamoto T., et al. Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure. Circulation 107 (2003) 2555-2558
5. Palladini G., Tozzi R., and Perlini S. Cardiac mast cells in the transition to heart failure: innocent bystanders or key actors?. J Hypertens 21 (2003) 1823-1825
6. Panizo A., Mindan F.J., Galindo M.F., et al. Are mast cells involved in hypertensive heart disease?. J Hypertens 13 (1995) 1201-1208
7. Patella V., de Crescenzo G., Lamparter-Schummert B., et al. Increased cardiac mast cell density and mediator release in patients with dilated cardiomyopathy. Inflamm Res 46 suppl 1 (1997) S31-S32
8. Patella V., Marino I., Arbustini E., et al. Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy. Circulation 97 (1998) 971-978
9. Shiota N., Rysa J., Kovanen P.T., et al. A role for cardiac mast cells in the pathogenesis of hypertensive heart disease. J Hypertens 21 (2003) 1935-1944
10. Batlle M., Roig E., Perez-Villa F., et al. Increased expression of the renin-angiotensin system and mast cell density but not of angiotensin-converting enzyme II in late stages of human heart failure. J Heart Lung Transplant 25 (2006) 1117-1125
11. Akgul A., Skrabal C.A., Thompson L.O., et al. Role of mast cells and their mediators in failing myocardium under mechanical ventricular support. J Heart Lung Transplant 23 (2004) 709-715
12. Akgul A., Youker K.A., Noon G.P., and Loebe M. Quantitative changes in mast cell populations after left ventricular assist device implantation. ASAIO J 51 (2005) 275-280
13. Jahanyar J., Youker K.A., Loebe M., et al. Mast cell-derived cathepsin G: a possible role in the adverse remodeling of the failing human heart. J Surg Res 140 (2007) 199-203
14. Skrabal C.A., Thompson L.O., Southard R.E., et al. Interaction between isolated human myocardial mast cells and cultured fibroblasts. J Surg Res 118 (2004) 66-70
15. Meininger C.J., Yano H., Rottapel R., et al. The c-kit receptor ligand functions as a mast cell chemoattractant. Blood 79 (1992) 958-963
16. Mitsui H., Furitsu T., Dvorak A.M., et al. Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. Proc Natl Acad Sci USA 90 (1993) 735-739
17. Tsai M., Takeishi T., Thompson H., et al. Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc Natl Acad Sci USA 88 (1991) 6382-6386
18. Valent P., Spanblochl E., Sperr W.R., et al. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. Blood 80 (1992) 2237-2245
19. Dastych J., and Metcalfe D.D. Stem cell factor induces mast cell adhesion to fibronectin. J Immunol 152 (1994) 213-219
20. Iemura A., Tsai M., Ando A., Wershil B.K., and Galli S.J. The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis. Am J Pathol 144 (1994) 321-328
21. Kinashi T., and Springer T.A. Steel factor and c-kit regulate cell-matrix adhesion. Blood 83 (1994) 1033-1038
22. Mekori Y.A., Oh C.K., and Metcalfe D.D. IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand. J Immunol 151 (1993) 3775-3784
23. Kirshenbaum A.S., Kessler S.W., Goff J.P., and Metcalfe D.D. Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells. J Immunol 146 (1991) 1410-1415
24. Kirshenbaum A.S., Goff J.P., Semere T., et al. Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13). Blood 94 (1999) 2333-2342
25. Jin D., Takai S., Yamada M., et al. Possible roles of cardiac chymase after myocardial infarction in hamster hearts. Jpn J Pharmacol 86 (2001) 203-214
26. Qu Z., Liebler J.M., Powers M.R., et al. Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. Am J Pathol 147 (1995) 564-573
27. Galli S.J. New concepts about the mast cell. N Engl J Med 328 (1993) 257-265
28. Da Silva C.A., Reber L., and Frossard N. Stem cell factor expression, mast cells and inflammation in asthma. Fundam Clin Pharmacol 20 (2006) 21-39
29. Nilsson G., Butterfield J.H., Nilsson K., and Siegbahn A. Stem cell factor is a chemotactic factor for human mast cells. J Immunol 153 (1994) 3717-3723
30. Echtenacher B., Mannel D.N., and Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381 (1996) 75-77
31. Maurer M., Echtenacher B., Hultner L., et al. The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells. J Exp Med 188 (1998) 2343-2348
32. Lorentz A., Schuppan D., Gebert A., Manns M.P., and Bischoff S.C. Regulatory effects of stem cell factor and interleukin-4 on adhesion of human mast cells to extracellular matrix proteins. Blood 99 (2002) 966-972
33. Frangogiannis N.G., Perrard J.L., Mendoza L.H., et al. Stem cell factor induction is associated with mast cell accumulation after canine myocardial ischemia and reperfusion. Circulation 98 (1998) 687-698
34. Matsuzawa S., Sakashita K., Kinoshita T., et al. IL-9 enhances the growth of human mast cell progenitors under stimulation with stem cell factor. J Immunol 170 (2003) 3461-3467
35. Wright H.V., Bailey D., Kashyap M., et al. IL-3-mediated TNF production is necessary for mast cell development. J Immunol 176 (2006) 2114-2121